SERIES B PREFERRED STOCK PURCHASE AGREEMENTSeries B Preferred • June 18th, 2010 • Activecare, Inc. • Communications equipment, nec • Delaware
VISTA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors listed on Exhibit A attached hereto (each a “Purchaser” and together the “Purchasers”), agree as follows:
Final Agreement May 11, 2010Activecare, Inc. • June 18th, 2010 • Communications equipment, nec • New Mexico
Whereas Vista Therapeutics, Inc. (Vista) is commercializing its patented nanowire-based biosensors that will permit almost immediate, multiplexed and label-free biomarker assessment; and whereas ActiveCare, Inc. (ActiveCare) is commercializing simple, continuous patient monitoring systems for in-home use. Vista and ActiveCare are in a perfect position to jointly develop and co-market an at-home patient monitoring system wherein an elderly patient’s biomarkers for certain disease conditions would be routinely assessed and the information automatically sent to an ActiveCare monitoring station for evaluation. This Memorandum of Understanding (MOU) outlines the main terms under which NanoBiosensorTM-based biomarker assessment products would be developed, fabricated, owned, distributed and supported.
